Evidence map›Paper›PMID 30951717›Full record

ArticleEuropean journal of pharmacology2019

Identification and biochemical analyses of selective CB

Caitlin E Scott, Yaliang Tang, Andrew Alt, Neil T Burford, Samuel W Gerritz, Lisa M Ogawa, Litao Zhang, Debra A Kendall

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Characterization of Subtype Selective Cannabinoid CBPharmaceuticals (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Effects of a CBJournal of cellular signaling · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Caitlin E ScottDepartment of Pharmaceutical Sciences, University of Connecticut, 69 N Eagleville Rd, Storrs, CT, 06269, USA.
Yaliang TangDepartment of Pharmaceutical Sciences, University of Connecticut, 69 N Eagleville Rd, Storrs, CT, 06269, USA.
Andrew AltBristol-Myers Squibb, Research and Development, 5 Research Parkway, Wallingford, CT, 06492, USA.
Neil T BurfordBristol-Myers Squibb, Research and Development, 5 Research Parkway, Wallingford, CT, 06492, USA.
Samuel W GerritzBristol-Myers Squibb, Research and Development, 5 Research Parkway, Wallingford, CT, 06492, USA.
Lisa M OgawaBristol-Myers Squibb, Research and Development, 5 Research Parkway, Wallingford, CT, 06492, USA.
Litao ZhangBristol-Myers Squibb, Research and Development, 5 Research Parkway, Wallingford, CT, 06492, USA.
Debra A KendallDepartment of Pharmaceutical Sciences, University of Connecticut, 69 N Eagleville Rd, Storrs, CT, 06269, USA. Electronic address: debra.kendall@uconn.edu.
Bristol-Myers Squibb (United States) · USUniversity of Connecticut · US

Funding

Beta-Arrestin Signaling from the Cannabinoid 2 and mu Opioid ReceptorsR21DA040920 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI KENDALL, DEBRA A · 2016 to 2017
$439k
NIDA NIH HHS R21 DA040920
6 · The paper itself

Abstract

Cannabinoid CB

Indexed as

Binding, CompetitiveDrug Evaluation, PreclinicalGuanosine 5'-O-(3-Thiotriphosphate)HEK293 CellsHumansJurkat CellsLigandsReceptor, Cannabinoid, CB2Guanosine 5'-O-(3-Thiotriphosphate)LigandsReceptor, Cannabinoid, CB2Cannabinoid CB(2) receptor agonistsCannabinoidsDrug discoveryReceptors

Identifiers

PMID30951717
PMCPMC6534466
OpenAlexW2928912053

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.